Use of sanglifehrin in HCV

Details for Australian Patent Application No. 2006259348 (hide)

Owner Novartis AG

Inventors Lin, Kai; Weidmann, Beat; Zimmermann, Kaspar

Agent Davies Collison Cave

Pub. Number AU-B-2006259348

PCT Pub. Number WO2006/138507

Priority 60/691,497 17.06.05 US

Filing date 15 June 2006

Wipo publication date 28 December 2006

Acceptance publication date 22 July 2010

International Classifications

A61K 31/5025 (2006.01) - ortho- or peri-condensed with heterocyclic ring systems

A61P 1/16 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 31/12 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

10 January 2008 PCT application entered the National Phase

  PCT publication WO2006/138507 Priority application(s): WO2006/138507

22 July 2010 Application Accepted

  Published as AU-B-2006259348

18 November 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006259349-Benzamide derivatives and uses related thereto

2006259344-New regimens for oral monophasic contraceptives